Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ryoichi Sawada"'
Autor:
Y Akita, T Yamasaki, Kazuki Sumiyama, Masaaki Noguchi, Tomohiro Kato, Ryoichi Sawada, Toshiyuki Sakurai, Masayuki Saruta, Haruna Miyashita, Ryosuke Miyazaki, Yusuke Nagata, Yuki Maruyama, Akihisa Hidaka
Publikováno v:
In Vivo
Background/Aim: Malignant lymphoma (ML) cases with overlapping gastrointestinal (GI) lesions are often encountered. We aimed to elucidate the importance of examining the GI tract in patients with ML and assess the overlap rate. Patients and Methods:
Autor:
Narikazu Boku, Ryoichi Sawada, Yusuke Nagata, Natsuko Okita, Hiroshi Imazeki, Atsuo Takashima, Masahiko Aoki, Hidekazu Hirano, Satoru Iwasa, Masayuki Saruta, Masashi Ishikawa, Hirokazu Shoji, Ken Kato, Yoshitaka Honma
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 9, p e0257551 (2021)
PLoS ONE, Vol 16, Iss 9, p e0257551 (2021)
Background In clinical practice, the same chemotherapeutic agents are occasionally reused (re-challenge) after failure of all available standard chemotherapy options for metastatic colorectal cancer (mCRC). However, the benefits of re-challenge chemo
Autor:
Ken Kato, Yasuhiro Shimada, Tsuyoshi Shirakawa, Hirokazu Shoji, Tetsuya Hamaguchi, Atsuo Takashima, Yoshitaka Honma, Natsuko Okita, Yasuhide Yamada, Naoki Takahashi, Kengo Nagashima, Yusuke Sasaki, Ryoichi Sawada, Akiko Nishikawa, Satoru Iwasa
Publikováno v:
Cancer Chemotherapy and Pharmacology. 74:1207-1215
Fluoropyrimidine plus platinum (FP)-based chemotherapy has been widely used as a first-line regimen for advanced or recurrent esophageal cancer, and taxanes have shown efficacy after FP-based chemotherapy, but there is no standard regimen for second-